This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Advanced Reporting Package Helps Drive Improvement At Home Health Agencies

Stocks in this article: NRCIB

LINCOLN, Neb., Aug. 22, 2013 (GLOBE NEWSWIRE) -- National Research Corporation is proud to announce the launch of Hospitalization Insights, a package of reports and dashboards that inform home health agencies about hospitalization rates, performance relative to their peers, and key opportunities for improvement. Understanding hospitalization metrics helps agencies enhance the patient experience, improve population health, and control healthcare costs. These key components of the product align with the mandates of the Affordable Care Act, including lowering costs by improving care across the continuum and providing a person-centered approach. Today's healthcare environment involves more hospitals and systems partnering with home health agencies in order to adopt optimal hospitalization management strategies. Jason Stevens, Vice President of Post-Acute Care at National Research, said the focus of hospitalization rates continues to increase throughout all of healthcare. "The Hospitalization Insights solution offers the level of data home health agencies need to spot opportunities for improvement, but also provide reports that will demonstrate your value as a care coordination partner to hospitals and other referral sources," Stevens said. Several benefits of the reports include real-time data focusing on the 30-day readmission rate and 60-day claims based Medicare admission rates, a patient risk assessment that provides statistics on potential hospitalization upon admission, and analysis reporting that showcases improvement opportunities. Learn more about the benefits. To learn more about Hospitalization Insights, to receive a demo, or to access a recording of a webinar on this topic contact National Research at info@nationalresearch.com. About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA|NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. Clinical outcomes and analytics solutions from National Research help identify a path to better quality outcomes and patient experiences for home health agencies. Recognized by Modern Healthcare as one of the largest patient satisfaction firms in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to info@nationalresearch.com, or visit www.nationalresearch.com .

CONTACT: Scott Smith
         Director of Marketing
         National Research Corporation
         800-388-4264
         scsmith@nationalresearch.com

National Research Corporation Logo

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs